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ABSTRACT
Background: The skin is a typical site for vascular tumours. Researches on primary cutaneous vascular tumours as a sub 
group of cutaneous soft tissue tumours are virtually non-existence in our environment in particular and Nigeria in general. 
The aim of this study is to elucidate the histopathological types of primary cutaneous vascular tumours as well as their age 
and sex distribution at the University of Benin Teaching Hospital.
Methods: It was a 10 year retrospective study that covered the period from 1st of January 2004 to 31st of December 2013. 
The archived records of the Department of Morbid Anatomy were consulted for all cases of histologically diagnosed 
cutaneous vascular tumours. The data generated was analysed using Statistical Package for Social Sciences, version 16.
Result: One hundred four cases (104) of cutaneous vascular tumours were encountered during the period of study under 
review. The mean age of cases with cutaneous vascular tumours was in the 4th decade while a slight female predilection 
was observed. Kaposi's sarcoma accounted for 73.08% of cases while the haemangiomas and angiosarcomas accounted 
for 25% and 1.92% of cutaneous vascular tumours respectively. Sexual predilection was slightly in favour of the females with 
Kaposi's sarcomas and haemangiomas. The mean ages for haemangioma, Kaposi's sarcoma and angiosarcoma were in 
the 3rd, 4th and 7th decades respectively.
Conclusion: Kaposi sarcoma was the most common cutaneous vascular tumour followed by haemangioma, while the least 
is the rare angiosarcoma. Cases with haemangiomas have the least mean age.
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INTRODUCTION
ascular neoplasms are a subset of V 1,2soft tissue tumours.  Like the soft tissue tumours, they vary in the 
2-4location from which they arise,  however 
the skin features prominently as a common 
3site of origin for vascular tumours.  Giving 
credence to this ,  the World Health 
Organization (WHO) had documented that 
the skin is the most common location for the 
1benign vascular tumours,  while it also 
typically serves as the site for Kaposi's 
sarcoma, a locally aggressive but rarely 
5metastasizing malignant vascular tumour.
Kaposi's sarcoma (KS) is a locally aggressive 
endothelial tumour that typically presents 
5with cutaneous lesions.  The population 
demographics and the risk associated with 
its development are the basis on which four 
clinical and epidemiological forms are 
4,5recognized.  They are: Classic indolent form 
occurring predominantly in elderly men of 
4-6Mediterranean/East European descent;  
African KS occurs in middle-aged adults and 
children in Equatorial Africa who are not 
5HIV infected;  Iatrogenic KS appearing in 
solid organ transplant recipients treated 
with immunosuppressive therapy and also 
in patients treated by immunosuppressive 
agents, particularly corticosteroids, for 
v a r i o u s  d i s e a s e s ;  A c q u i r e d 
immunodeficiency syndrome - associated 
 4-6KS (AAKS).  
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In sub – Saharan Africa in 2012, Kaposi's 
rd th thsarcoma ranked the 3 , 5  and 5  in position 
amongst the most frequent cancers in males, 
females and both sexes respectively. The number 
of mortalities in this area in males and females 
were 16218 and 9134 respectively. The age 
adjusted mortality rate/100,000 is 6.5 and 3.7 in 
7males and females respectively.  Previous studies 
in Nigeria have reported the incidence of Kaposi's 
sarcoma in relation to other malignant cutaneous 
tumour that  ranges from kerat inocyt ic 
(squamous and basal cell carcinomas) to 
melanocytic (malignant melanoma) through soft 
t i ssue  neoplasm (dermatofibrosarcoma 
protuberance  and  angiosarcoma) ,  and 
haematolymphoid tumours  (cutaneous 
8-15lymphomas),  however, our own study would 
look at KS through the window of cutaneous 
vascular tumours, a sub group of cutaneous 
soft tissue tumours.  The prevalence of Kaposi's 
sarcoma in these previous studies that looked at it 
in relation to the other aforementioned malignant 
8-15cutaneous tumours ranged from 7.5-38%.  
Studies done in Burkina Faso, Togo, Ghana, 
Tanzania and Tunisia have shown that 
Kaposi's sarcoma accounted for 80.6, 13.9, 6.5, 
10.4 and 4.5% respectively of all malignant 
16-20 18skin tumours.  Barro Traore et al  reported 
that the predominance of KS in their study 
may be explained by the high prevalence of 
HIV infection (2.7-6.5%) in Burkina Faso. 
Several studies have shown that KS is more 
common in males than in females. The 
earliest of these studies in Nigeria was 
21published in the early 60s by MaClean,  who 
collected data from every region of the 
country. He reported a male to female ratio of 
7.5:1. Subsequently other studies in Nigeria 
w e r e  r e s t r i c t e d  t o  t h e i r  r e s p e c t i v e 
15 9environments i.e. Benin city,  Calabar,  
22 23,24 25Abuja,  Zaria  and Jos.  These studies also 
16reported a male predilection. Mseddi et al  
17(Tunisia) and Chalya et al  (Tanzania) 
reported similar findings. In contrary, 
26Akinde et al  (Lagos) reported a female 
9 27predilection. Asuquo  and Onunu et al  
observed that the number of  females with 
the disease had increased due to HIV 
17infection, while Chalya et al  reported that 
HIV infection had increased the prevalence of 
KS, thus making it the second most common 
dermatological malignant tumour in their 
environment. Surprisingly, only a handful of 
studies reported on the peak age of KS. 
25Mandong et al  (Jos) reported a peak age that 
rd thspanned from the 3  to the 5  decade while 
15Forae and Olu-Eddo reported a peak age in  
ththe 4  decade. The reported mean ages were 
rd thin the 3  and 4  decades. Forae and Olu-
15 26 27Eddo, Akinde et al,  Onunu et al,  Ahmed et 
23 24al,  and Ahmed et al  reported a mean age of  
48, 45. 36.3 32 and 39 years respectively. 
The human herpes virus 8 (HHV-8) has been 
implicated as the oncogenic virus associated 
4-6,28with this disease.  The role of growth 
factors and chromosomal aberrations in its 
5pathogenesis have been reported.  They 
present to the clinicians as patches, plaques, 
nodules of the different sizes that are 
5,29confined to the skin.  Microscopic features 
of patch stage shows slit-like spaces between 
the collagen bundles and extravasated red 
29blood cells.  Microscopic features of plaque 
stage shows spindle cell proliferation and 
irregular vascular spaces while that of 
nodular stage shows solid proliferation of 
spindle-shaped cells, nuclear atypia, mitotic 
29figures and extravasated red blood cells.
Angiosarcoma is relatively rare when 
29-32 compared to the benign vascular tumours.
31Albores-Saavedra et al  reported very slight 
male predilection (222 males: 212 Females) 
with a male to female ratio of 1.1:1. Ohira et 
33 34al  (M:F of 1.8:1) and Lydiatt et al  (M:F of 
2.6:1) reported a male preponderance in their 
35respective studies, while  Requeena et al  
(M:F of 1:2.2) reported a female predilection. 
Perhaps the sample size and the duration of 
study may have played a role in this 
disparity. The mean and median ages were 
reported from previous studies to occur in 
31the elderly. Albores-Saavedra et al  reported 
a mean age of 73 years in their study. The 
mean and median ages have been previously 
35documented by Requeena et al  as 67 and 71 
34years respectively, while Lydiatt et al  
124
Nigerian Journal of Medicine, Vol. 27  No. 1, April - June, 2018 ISSN 1115-2613
reported a median age of 67 years. The 
m a j o r i t y  o f  a n g i o s a r c o m a  a r i s e 
spontaneously and are  of  unknown 
30etiology.  Angiosarcoma can occur as 
complication of longstanding lymphedema 
2 9 , 3 0and radiation therapy.  Cytogenetic 
changes found include gains of 5pter-p11, 
8p12-qter, and 20pter-q12, losses of 7pter-p15 
3 0and 22q13-qter,  and –Y.  Under the 
microscope, it is seen as an asymmetrical 
collection of angulated, irregular vascular 
channels that are infiltrating between 
co l lagen  bundles  and  are  l ined  by 
hyperchromatic irregular nuclei and 
prominent nucleoli with numerous mitotic 
2 9figure .  Appear  as  dusky i rregular 
erythematous plaques that are frequently 
 29ulcerated.
Hemangiomas constitute 7% of all benign 
4tumours of infancy and childhood.  Harris et 
al in their study reported that there was no 
sexual predilection with a peak incidence in 
the second decade.  Studies done in 
36 37 38Cameroon,  Benin city  and Sagamu  
reported that haemangiomas were the most 
common benign vasoformative tumours 
accounting for 80.68%, 68% and 94.4% 
respectively of all cases of vasoformative 
tumours. It arises from developmental and 
39acquired proliferation of blood vessel.  
Under the microscope, they are seen as well-
circumscribed proliferation of small vessels 
lined by flattened endothelial cells. While the 
congenital lesions are typically lobulated 
with several vessels, the acquired lesion 
characteristically develop luminal ectasia 
2 9with age.  Appear clinically as small 
 29strawberry-red lesion of less than 1 cm.
In Africa, there is paucity of data on vascular 
tumours with the exception of Kaposi's 
36sarcoma.  Researches on primary cutaneous 
vascular tumours (CVTs) as a sub group of 
cutaneous soft tissue tumours are virtually 
non-existence in our environment in 
particular and Nigeria in general. The aim of 
t h i s  s t u d y  i s  t o  e l u c i d a t e  t h e 
histopathological types of primary cutaneous 
vascular tumours as well as their age and sex 
distribution at the University of Benin 
Teaching Hospital (UBTH), Benin City, Edo 
State. The histopathological pattern of 
primary CVTs in our environment if 
elucidated would offer the data baseline for 
the subject matter. The Pathologist and 
Dermatologist would then be acquainted 
with the most likely primary CVTs they 
would be encountering in their day to day 
respective jobs. This will also assist in prompt 
clinical and histopathological diagnosis as 
the ruling in or ruling out of tumours not 
within these base line data becomes relatively 
easy taking into cognizance their relative 
frequencies, age and sex distribution. 
METHODOLOGY
A ten year retrospective study was embarked 
s tupon between January 1 ,  2004 and 
stDecember 31 , 2013 at the Department of 
Morbid Anatomy, UBTH. The subjects of 
interest were all cases of histologically 
diagnosed primary cutaneous vascular 
tumours at the UBTH. The biodata and 
clinical information were collected from 
documented archived records of the 
department and hospital. The slides were 
r e t r i e v e d  a n d  r e v i e w e d .  T h e 
histopathological diagnosis, the biodata and 
avai lable  c l in ica l  informat ion were 
documented on a data spread sheet created 
on excel. The data was subsequently 
transferred to Statistical Package for Social 
Sciences, version 16 (SPSS 16, SPSS Inc. 
Chicago, Illinois, United States of America). It 
was then analysed using the SPSS.  The 
permission for the study was requested and 
duly obtained from the Ethics and Research 
Committee of the University of Benin 
Teaching Hospital. 
RESULTS
There were 104 cases of cutaneous vascular 
tumours (CVTs) observed during the period 
of study under review. Seventy eight (78) 
125
Nigerian Journal of Medicine, Vol. 27  No. 2, April - June, 2018 ISSN 1115-2613
were malignant while 26 were benign. 
Malignant CVTs were represented by 
Kaposi's sarcoma and angiosarcoma, while 
the haemagioma's represented the benign 
CVTs. The mean age of patients with CVTs 
was 35.97 years (SD=16.67), while their 
median and modal ages were 35 and 32 years 
respectively. Their ages ranged from 1 to 75 
years with a range of 74 years. Cutaneous 
vascular tumours occurred slightly more 
commonly in females giving a female to male 
ratio of 1.12:1, (Table 1).
Kaposi's sarcoma was the most common 
tumour in this study and it represented 
73.08% of CVTs. It also doubled as the most 
common primary malignant CVT accounting 
for 76 cases which represented 97.44%. 
The age and sex distribution is as shown in 
Table 1 and 2. 
Angiosarcoma was the least common CVT 
observed. It accounted for 2 cases of the study 
population and this represented 1.92 % and 
2.56% all CVTs and malignant cutaneous 
tumours respectively. The age and sex 
distribution is as shown in Table 1 and 2. 
Haemangioma accounted for 26 cases which 
r e p r e s e n t e d  2 5 % ,  o f  c u t a n e o u s 
vasoformative tumour. The mean age for 
those cases with histological diagnosis of 
haemangioma was 24.04 years (SD = 19.28). 
The age and sex distribution is as shown in 
Table 1 and 2.
Table 1: Age group and sex distribution of cutaneous vascular tumours
Age KS HAEM AGS Total





- - 1 4 - - 5





















































































TOTAL 36 40 12 14 1 1 104
KEY: KS=Kaposi's sarcoma. Haem=Haemangioma. AGS=Angiosarcoma)
DISCUSSION
In this study, the mean age of cutaneous 
thvascular tumour (CVTs) was in the 4  decade, 
while a slight female predilection was 
observed. Cutaneous malignant vascular 
tumours were more prevalent when 
compared to their benign counterparts. 
Paucity of data on CVTs has limited the 
comparison of the above findings with other 
studies, more so that with the exception of  
KS, data on vascular tumours are generally 
36lacking in the Africa continent.  Kaposi's 
sarcoma (KS) and angiosarcoma were the 2 
malignant cutaneous vascular tumours 
encountered in this study. The former was by 
far the more common to a tune that makes it 
double as the most common cutaneous 
vascular and malignant vascular tumour. As 
Table 2: Frequency, sex distribution, mean and peak ages of subtypes of cutaneous vascular tumour
 
 FREQUENCY    












       
  
Malignant 
             KS 76 36 40 1:1.1 39.30 ±13.22 30 – 39 
         AGS 2 1 1 1:1 64.54 ±   4.95  
   Benign        
        HAEM 26 12 14 1:1.16 24.04±19.28 10 – 19 
    TOTAL  104 49 55 1:1.12   
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earlier noted in the introductory section, 
previous studies in Nigeria have reported the 
incidence of Kaposi's sarcoma in relation to 
other malignant cutaneous tumour unlike 
this study that has looked at it in relation to 
other vascular tumours. Paucity of data on 
KS from this perspective has greatly limited 
the comparison of its prevalence with similar 
studies. Suffice to say that, the noted 
prevalence of Kaposi's sarcoma in this study 
(73.08%) is much higher than the value of the 
upper limit of the reference range (7.5-38 %) 
8-15 of this lesion in previous studies that 
looked at it in relation to the other malignant 
cutaneous tumours. The prevalence of KS 
m i g h t  b e  r e l a t e d  t o  t h e  h u m a n 
immunodeficiency virus (HIV) infection 
scourge with accompanying HIV associated 
9,27KS.  Most previous studies done in Nigeria, 
Tunisia and Tanzania reported a male 
9,15,16,21,25,27predilection.  This is contrary to our 
own finding that reported a slight female 
predilection (Male to Female ratio of 1.12:1). 
26Similar to our own observation, Akinde et al   
reported a female predilection. This disparity 
may be related to the increase in the number 
of females affected with AIDS associated 
9,27 thKS.   The peak incidence was noted in the 4  
decade and this is consistent with the 
15previous study done in Benin city,  unlike 
25  the study done in Jos by Mandong et al, that 
reported a peak incidence that spanned from 
rd ththe 3  to the 5  decade. The mean age of KS 
was observed to be 39.3 years which is 
comparatively similar to that of previous 
23-25,27studies from Benin City, Zaria and Jos.  It 
was however at slight variance with a 
previous study from Lagos and another 
previous study from Benin city that reported 
t h e  m e a n  a g e  o f  4 5  a n d  4 8  y e a r s 
15,26respectively.
Two cases of cutaneous angiosarcoma seen in 
ththis study occurred in the elderly (7  decade), 
accounting for 1.92 % and 2.56% all CVTs and 
malignant cutaneous vascular tumours 
(mCVTs) respectively. These figures give the 
impression of a rare tumour. This is in 
keeping with previous documented 
31,32,37,38,40reports.  This study noted no sex 
predilection. This is at variance with previous 
s tudies  that  reported a  s l ight  male 
31 33,34preponderance,  a male preponderance  
35and a female predilection.  While no concrete 
reason may be given for these disparities, the 
sample size and study duration may play a 
31,33-35role. These other studies  had sample 
sizes that ranged from 16 to 434 cases of 
angiosarcomas and a duration that spanned 
from 11 – 34 years. This is unlike our own 
study that observed 2 cases of angiosarcoma 
over a span of 10 years. 
In this study, haemangiomas were the sole 
benign vasoformative tumour. It is also the 
second most common vasoformative tumour 
after Kaposi's sarcoma. This is consistent 
with reports from previous studies done in 
Cameroon, Benin city and Sagamu that 
reported this lesion as the most common 
36-38benign vascular tumour.  Similar to the 
41observation of Harris et al,  (Indiana, United 
States of America) this study reported a peak 
41age in the second decade. While Harris et al  
reported equal prevalence in male and 
female patients, this study noted only a slight 
female predilection (Male: Female ratio of 
411:1.16). Harris et al  concluded their study by 
refuting the female hormonal influence on 
the induction of cutaneous capillary 
h a e m a n g i o m a .  T h i s  s l i g h t  f e m a l e 
predilection in our study may seem to 
 41support this position of Harris et al,  but it is 
limited by the sample size (26 cases against 
325 cases), more so that their study collated 
data from multi-centres.
 
From the foregoing, CVTs are very slightly 
more common in the female; their mean age 
thwas in the 4  decade. Kaposi sarcoma was the 
most common cutaneous vascular tumour 
followed by haemangioma, while the least is 
the rare angiosarcoma. Kaposi's sarcoma and 
haemangioma had slight female predilection 
whi le  angiosarcoma had  no  sexual 
predilection. The peak ages was noted in the 
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